INmune Bio (INMB)

• Market cap: $33.5M
• 1 day: -6.67%
• 5 days: -10%
• 1 month: -18.18%
• 3 months: -0.79%
• 6 months: -34.03%
• Year to date: -18.18%
• 1 year: -82.86%
• 5 years: -92.11%
• 10 years: -84.23%
• Sector: Healthcare
• Industry: Biotechnology

About: INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Employees: 21